Latest filing published 18 Oct 2019 for Antibe Therapeutics Inc..
All filings by Nicolas Bourgeois on record concern Antibe Therapeutics Inc. Between 21 March 2018 and 3 October 2019, the trades on record add up to 3 filings.
The open-market side counts 1 purchase for €17k alongside 1 sale for €165k. Sales outweigh purchases by €148k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise.
The latest filing, published on 18 October 2019, reports an option exercise in Antibe Therapeutics Inc. The last insider purchase was made public on 18 September 2018, 2,960 days ago. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations